Eli Lilly's Earnings Report Impact on Traders Amid Limited Drug Supplies
Monday, 29 April 2024, 17:28
Eli Lilly's Earnings and Drug Supplies
The Food and Drug Administration has revealed that supplies of Zepbound and Mounjaro will be restricted through the second quarter. Only one dosage is expected to be exempt from this limitation.
Impact on Traders
Traders are closely monitoring the situation as these supply constraints could influence the performance of Eli Lilly's stock.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.